{"id":191000,"date":"2022-02-04T13:16:43","date_gmt":"2022-02-04T11:16:43","guid":{"rendered":"https:\/\/medicare-group.hu\/laboratory-tests\/laboratory-test-packages\/laboratory-testing-of-female-sex-hormones\/"},"modified":"2025-04-10T14:46:58","modified_gmt":"2025-04-10T12:46:58","slug":"laboratory-testing-of-female-sex-hormones","status":"publish","type":"page","link":"https:\/\/medicare-group.hu\/en\/laboratory-tests\/laboratory-test-packages\/laboratory-testing-of-female-sex-hormones\/","title":{"rendered":"Laboratory testing of female sex hormones"},"content":{"rendered":"

Laboratory testing of female sex hormones<\/h1>\n\t
\n\t\t
\n\t\t\t

In the female sex hormones laboratory package, we examine cycle-dependent female sex hormones in case of bleeding disorders and infertility problems. Cycle-dependent hormone levels are monitored by two blood draws on day 3 (AMH, FSH, LH, testosterone, prolactin, oestradiol) and day 21 (progesterone) of the cycle.<\/p>\n

For women taking contraceptives, the result cannot be evaluated, so it is recommended that a laboratory test be performed after leaving the contraceptive.<\/strong><\/p>\n

The first blood draw takes place on day 3 of the menstrual cycle (AMH, FSH, LH, testosterone, prolactin, oestradiol). The first half of the cycle is the follicular phase and the period after ovulation is the luteal phase. At the first blood draw (H1), we examine a complete line of hormones, when problems arising from the functioning of glands and organs that produce hormones can be revealed, so we get a general picture of hormone homeostasis and organ function, that is, whether the uterus is able to receive a possibly fertilized egg. The second blood draw of cycle-dependent hormones takes place on day 21 (progesterone).<\/p>\n

In the second half of the cycle, a repeated female hormone test (H2) on day 21 seeks to clarify whether hormonal processes are developing properly, whether the fertilized egg could be implanted in the uterus, whether there is corpus luteum insufficiency, or other problems.<\/strong><\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div>

AMH (anti-M\u00fcllerian hormone)<\/h3>\n\t
\n\t\t
\n\t\t\t

Its examination provides an opportunity to assess the reserves of the ovaries. Hormone levels gradually decrease during the female fertility phase, which is associated with a decrease in the number of eggs\/follicles with age. Estimation of ovarian reserve can predict the success of ovarian stimulation as well as the time remaining until menopause.<\/p>\n

Conditions with elevated AMH levels may include polycystic ovary syndrome (PCOS) and ovarian granulosa-cell tumours.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n

FSH<\/h3>\n\t
\n\t\t
\n\t\t\t

FSH (follicle-stimulating hormone, follicular maturation hormone) is a sex hormone produced in the anterior lobe of the pituitary gland. Although FSH and LH are required for normal sexual function in both men and women, the process of excretion in the body is very different for the two sexes.<\/p>\n

FSH initiates the growth and development of ovarian follicles. During ovulation, the follicle ruptures, the egg is released and the corpus luteum forms. In menopause, decreased ovarian function results in a decrease in oestradiol secretion, resulting in a significant increase in circulating FSH levels.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n

When may the test be needed?<\/h4>\n\t
\n\t\t
\n\t\t\t

Diagnosing menstrual disorders, infertility, menopause, pituitary gland and diseases associated with ovarian disorders.<\/p>\n

When a woman reaches menopause and her ovaries stop functioning, FSH levels rise.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div>

\n\t
\n\t\t\n\t\t
\n\t\t\t
\"labor<\/div>\n\t\t<\/figure>\n\t<\/div>\n